IA
TBIO

IFP Advisors’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

IFP Advisors’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-181
Closed -$3.38K – 3395
2023
Q3 		$3.38K Hold
181
– – ﹤0.01% 2663
2023
Q2 		$5.13K Buy
+181
New +$7.22K ﹤0.01% 2532

Other funds holding TBIO

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $29.1B AUM 22.79% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

IFP Advisors's TBIO Position: Q4 2023 in Review

IFP Advisors sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q4 2023, closing a stake of 181 shares — an estimated $3.38K sold.

IFP Advisors first reported a position in TBIO in Q2 2023 and held it in 2 quarters. The position peaked at $5.13K in Q2 2023. 24 funds tracked by Wall St. Rank hold TBIO as of Q4 2023.

  • IFP Advisors reported no remaining Telesis Bio, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • IFP Advisors sold 181 Telesis Bio, Inc. Common Stock shares in Q4 2023, an estimated $3.38K.
  • IFP Advisors first reported a position in Telesis Bio, Inc. Common Stock in Q2 2023 and held it in 2 quarters.
  • IFP Advisors's Telesis Bio, Inc. Common Stock position peaked at $5.13K in Q2 2023.
  • 24 funds tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q4 2023.

Based on IFP Advisors's 13F filing for Q4 2023, filed 9 Jan 2024.